# Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB

**Authors:** T.M.P. Nguyen, T.H.M. Le, C.S.C. Merle, L. Guglielmetti, N.L. Nguyen, V.L. Dinh, B.H. Nguyen, T.T.T. Hoang, V.N. Nguyen, S. Callens, T. Decroo

PMC · DOI: 10.5588/ijtldopen.25.0494 · IJTLD OPEN · 2026-02-11

## Full-text entities

- **Diseases:** TB (MESH:D014390)
- **Chemicals:** rifampicin (MESH:D012293)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12991738/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12991738/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12991738/full.md

---
Source: https://tomesphere.com/paper/PMC12991738